Wilcoxon rank-sum tests showed that the SETD2 mut + group had a significantly higher MSIsensor score than that the SETD2 mut- group in endometrial carcinoma, colorectal adenocarcinoma, and stomach adenocarcinoma (Fig. 3A). This evidence concerns the gene SETD2 and colorectal adenocarcinoma.